2017
DOI: 10.1111/joim.12716
|View full text |Cite
|
Sign up to set email alerts
|

Supplemental oxygen therapy does not affect the systemic inflammatory response to acute myocardial infarction

Abstract: In a randomized controlled setting of normoxemic patients with AMI, the use of supplemental oxygen did not have any significant impact on the early release of systemic inflammatory markers.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 58 publications
0
0
0
1
Order By: Relevance
“…PCI is currently the best treatment for STEMI, which can restore reperfusion as early as possible and reduce the infarct area. However, ischemia-reperfusion injury can cause slow blood flow in myocardial tissue and no-reflow in the kidney, which seriously affects cardiac function and the prognosis of patients (5). Intensive statin therapy for STEMI patients before PCI can effectively reduce ischemia-reperfusion injury (6,7).…”
Section: Introductionmentioning
confidence: 99%
“…PCI is currently the best treatment for STEMI, which can restore reperfusion as early as possible and reduce the infarct area. However, ischemia-reperfusion injury can cause slow blood flow in myocardial tissue and no-reflow in the kidney, which seriously affects cardiac function and the prognosis of patients (5). Intensive statin therapy for STEMI patients before PCI can effectively reduce ischemia-reperfusion injury (6,7).…”
Section: Introductionmentioning
confidence: 99%
“…Die bisherigen Studienergebnisse wie auch die Ergebnisse der Analyse von Page et al sollten zum gegenwärtigen Zeitpunkt als "Hypothesen-generierend" gesehen werden: Diese Daten liefern die Rationale für die Initiierung von randomisierten Studien, die die konven-tionelle Praxis der Sauerstoffgabe gegen eine restriktive Sauerstofftherapie evaluiert. Den Kollegen aus Schweden ist zu danken, da sie diese grundlegende Frage bei Patienten mit Myokardinfarkt und Normoxämie zwischenzeitlich überzeugend klären konnten [1,21,23].…”
unclassified